ELMWOOD PARK, N.J., July 30, 2019 /PRNewswire/ -- BioReference Laboratories, Inc. ("BioReference") announced today that it is mailing letters to some of its patients whose information may have been included in the American Medical Collection Agency ("AMCA") security incident previously announced.
BioReference used AMCA for billing collection services, and on
This incident did not affect all BioReference patients; but only certain patients who were subject to billing collections with AMCA.
BioReference deeply regrets any concern or inconvenience this incident may cause its patients. BioReference recommends affected patients to review the statements they receive from their health care providers. If they see services they did not receive, they should contact the provider immediately. BioReference has since ceased doing business with AMCA and is takings steps to retrieve and secure all BioReference patient information contained in AMCA's systems. BioReference established a dedicated call center for patients to contact with any questions, at (US) 1-833-963-0524, Monday through Friday, 9:00 a.m. to 6:30 p.m. Eastern Time.
View original content:http://www.prnewswire.com/news-releases/bioreference-notifies-patients-in-amca-incident-300893584.html
SOURCE BioReference Laboratories, Inc.
Subscribe to our Free Newsletters!